| Hunter's tropical medicine and emerging infectious diseases ET Ryan, DR Hill, T Solomon, N Aronson, TP Endy Elsevier Health Sciences, 2019 | 275 | 2019 |
| Remdesivir in patients with acute or chronic kidney disease and COVID-19 ML Adamsick, RG Gandhi, MR Bidell, RH Elshaboury, RP Bhattacharyya, ... Journal of the American Society of Nephrology 31 (7), 1384-1386, 2020 | 199 | 2020 |
| Addressing inpatient beta-lactam allergies: a multihospital implementation KG Blumenthal, ES Shenoy, AR Wolfson, DN Berkowitz, VA Carballo, ... The journal of allergy and clinical immunology: In practice 5 (3), 616-625. e7, 2017 | 113 | 2017 |
| Outcomes from an inpatient beta-lactam allergy guideline across a large US health system KG Blumenthal, Y Li, JT Hsu, AR Wolfson, DN Berkowitz, VA Carballo, ... Infection Control & Hospital Epidemiology 40 (5), 528-535, 2019 | 47 | 2019 |
| Baseline procalcitonin as a predictor of bacterial infection and clinical outcomes in COVID-19: A case-control study NJ Atallah, HM Warren, MB Roberts, RH Elshaboury, MR Bidell, ... PLoS One 17 (1), e0262342, 2022 | 34 | 2022 |
| Multisociety statement on coronavirus disease 2019 (COVID-19) vaccination as a condition of employment for healthcare personnel DJ Weber, JA Al-Tawfiq, HM Babcock, K Bryant, M Drees, R Elshaboury, ... Infection Control & Hospital Epidemiology 43 (1), 3-11, 2022 | 31 | 2022 |
| Antimicrobial stewardship: principles and practice K LaPlante, C Cunha, H Morrill, L Rice, E Mylonakis CABI, 2016 | 28 | 2016 |
| Antibiotic pharmacodynamics JC Rotschafer, DR Andes, KA Rodvold Humana press, 2016 | 20 | 2016 |
| Beta-lactam antibiotic test doses in the emergency department M Maguire, BD Hayes, L Fuh, R Elshaboury, RG Gandhi, S Bor, ... World Allergy Organization Journal 13 (1), 100093, 2020 | 18 | 2020 |
| Fecal Microbiota Transplantation and Emerging Treatments for Clostridium difficile Infection KD Gens, RH Elshaboury, JS Holt Journal of pharmacy practice 26 (5), 498-505, 2013 | 17 | 2013 |
| Opportunities to improve antibiotic appropriateness in US ICUs: a multicenter evaluation KK Trivedi, R Bartash, AR Letourneau, L Abbo, J Fleisher, C Gagliardo, ... Critical care medicine 48 (7), 968-976, 2020 | 12 | 2020 |
| A retrospective analysis of treatment and clinical outcomes among patients with methicillin-susceptible Staphylococcus aureus bloodstream isolates possessing detectable mecA by … D Jones, RH Elshaboury, E Munson, TJ Dilworth Antimicrobial agents and chemotherapy 62 (1), 10.1128/aac. 01396-17, 2018 | 11 | 2018 |
| Prospective evaluation of a continuous infusion vancomycin dosing nomogram in critically ill patients undergoing continuous venovenous haemofiltration JH Sin, K Newman, RH Elshaboury, DD Yeh, MA de Moya, H Lin Journal of Antimicrobial Chemotherapy 73 (1), 199-203, 2018 | 11 | 2018 |
| Therapeutic drug concentrations of isavuconazole following the administration of isavuconazonium sulfate capsules via gastro‐jejunum tube: a case report ML Adamsick, RH Elshaboury, T Gift, MK Mansour, CN Kotton, RG Gandhi Transplant Infectious Disease 21 (2), e13048, 2019 | 10 | 2019 |
| Pharmacist-driven management of chemotherapy induced nausea and vomiting in hospitalized adult oncology patients. A retrospective comparative study R Elshaboury, K Green INNOVATIONS in pharmacy 2 (3), 2011 | 9 | 2011 |
| Results of a local combination therapy antibiogram for Pseudomonas aeruginosa isolates: is double worth the trouble? M Song, TJ Dilworth, E Munson, J Davis, RH Elshaboury Therapeutic Advances in Infectious Disease 4 (6), 165-170, 2017 | 8 | 2017 |
| HCV therapy follow-up fractionation (CTF2) by intra-PBMC nested RNA PCR recognizes early virologic response and relapse MDA Abd Alla, SA Elibiary, RH Elshaboury, GY Wu, RM Dawood, ... Journal of Clinical and Translational Hepatology 6 (2), 147, 2018 | 7 | 2018 |
| IV push administration of medications reconstituted with 0.9% sodium chloride injection RG Gandhi, SN Steiger, RH Elshaboury, JT Lund The Bulletin of the American Society of Hospital Pharmacists 75 (12), 851-852, 2018 | 6 | 2018 |
| Remdesivir use and outcomes during the FDA COVID-19 emergency use authorization period RH Elshaboury, MM Monk, LM Bebell, MR Bidell, ML Adamsick, ... Therapeutic Advances in Infectious Disease 8, 20499361211046669, 2021 | 5 | 2021 |
| Assessment and optimization of the empiric treatment of urinary tract infections in an academic emergency department observation unit SK Patel, RH Elshaboury, RG Gandhi, BD Hayes, BJ Yun, JL Koehl The Journal of Emergency Medicine 58 (2), 203-210, 2020 | 4 | 2020 |
Meagan L. AdamsickPresbyterian Medical Center - Novant HealthVerified email at novanthealth.org
